BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1721315)

  • 1. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
    Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of FK 506, mycophenolic acid, and bredinin on OKT-3-, PMA-, and alloantigen-induced activation molecule expression on cultured CD4+ and CD8+ human lymphocytes.
    Woo J; Zeevi A; Yao GZ; Strednak J; Todo S; Thomson AW
    Transplant Proc; 1991 Dec; 23(6):2939-40. PubMed ID: 1721319
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive agents: recent developments in molecular action and clinical application.
    Gerber DA; Bonham CA; Thomson AW
    Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.
    Zeevi A; Yao GZ; Venkataramanan R; Duquesnoy RJ; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):781-3. PubMed ID: 7679843
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
    Cooper MH; Gregory SH; Thomson AW; Fung JJ; Starzl TE; Wing EJ
    Transplant Proc; 1991 Dec; 23(6):2957-8. PubMed ID: 1721326
    [No Abstract]   [Full Text] [Related]  

  • 6. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopharmacology of new xenobiotic immunosuppressive molecules.
    Morris RE
    Semin Nephrol; 1992 Jul; 12(4):304-14. PubMed ID: 1384096
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
    Lemster B; Woo J; Strednak J; Wang SC; Todo S; Starzl TE; Thomson AW
    Transplant Proc; 1992 Dec; 24(6):2845-6. PubMed ID: 1281576
    [No Abstract]   [Full Text] [Related]  

  • 10. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
    Gregory CR; Pratt RE; Huie P; Shorthouse R; Dzau VJ; Billingham ME; Morris RE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):770-1. PubMed ID: 7679842
    [No Abstract]   [Full Text] [Related]  

  • 12. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
    Mattila PS
    Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
    [No Abstract]   [Full Text] [Related]  

  • 13. [New immunosuppressive drugs in transplantation].
    Surdacka E; Sułowicz W; Surdacki A
    Przegl Lek; 1994; 51(8):347-54. PubMed ID: 7532870
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine, FK-506 and other drugs in organ transplantation.
    Morris PJ
    Curr Opin Immunol; 1991 Oct; 3(5):748-51. PubMed ID: 1721824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
    Nakajima H; Oka T
    Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
    [No Abstract]   [Full Text] [Related]  

  • 16. Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin.
    Siekierka JJ
    Immunol Res; 1994; 13(2-3):110-6. PubMed ID: 7539823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.
    Böhler T; Waiser J; Budde K; Lichter S; Jauho A; Fritsche L; Korn A; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):2195-7. PubMed ID: 9723438
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.
    Francavilla A; Starzl TE; Carr B; Azzarone A; Carrieri G; Zeng QH; Porter KA
    Transplant Proc; 1991 Dec; 23(6):2817-20. PubMed ID: 1721287
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation.
    Wu J; Palladino MA; Figari IS; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):238-40. PubMed ID: 1703683
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapamycin.
    Carlson RP; Sehgal SN; Lewis AJ
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S129. PubMed ID: 8324938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.